Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kenneth Lim, MD FRCSC
University of British Columbia
Principal Investigator - Peter von Dadelszen, BMedSc, MBChB, DipObst, DPhil,
University of British Columbia
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Alexandra Hospital
Edmonton, Alberta, Canada
- Bc Women'S Hospital/university of British Columbia
Vancouver, British Columbia, Canada
- London Health Sciences Centre
London, Ontario, Canada
- Chu Sainte-Justine
Montreal, Quebec, Canada
- Chu de Quebec - Universite Laval
Québec, Quebec, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2017
- Primary completion
- 31 Jul 2018
- Completion
- 30 Apr 2019
- Last update posted
- 11 Feb 2020
- Registered enrollment
- 21
- Registry id
- NCT02442492
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.